BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28855534)

  • 1. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
    Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
    Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy.
    Zhang B; Shi W; Jiang T; Wang L; Mei H; Lu H; Hu Y; Pang Z
    Oncotarget; 2016 Sep; 7(38):62607-62618. PubMed ID: 27566585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.
    Klenke FM; Abdollahi A; Bischof M; Gebhard MM; Ewerbeck V; Huber PE; Sckell A
    Strahlenther Onkol; 2011 Jan; 187(1):45-51. PubMed ID: 21234531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.
    Kim JY; Chung SW; Kim SY; Byun Y
    Pharm Res; 2015 Jul; 32(7):2318-27. PubMed ID: 25585956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.
    Guo P; Song S; Li Z; Tian Y; Zheng J; Yang X; Pan W
    Int J Pharm; 2015; 486(1-2):356-66. PubMed ID: 25840274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice.
    Zhang B; Jiang T; She X; Shen S; Wang S; Deng J; Shi W; Mei H; Hu Y; Pang Z; Jiang X
    Biomaterials; 2016 Jul; 96():63-71. PubMed ID: 27149664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
    Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y
    J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo.
    Zhu Y; Wang X; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2017 Mar; 250():9-19. PubMed ID: 28163212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
    Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
    Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.